Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-021661
Filing Date
2016-03-14
Accepted
2016-03-14 19:46:27
Documents
2
Period of Report
2016-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1688
2 ex24duliege.txt EX-24 3026
  Complete submission text file 0001179110-16-021661.txt   6011
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4001 MIRANDA AVENUE PALO ALTO CA 94304
Business Address
Duliege Anne-Marie (Reporting) CIK: 0001419579 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29889 | Film No.: 161505257